drugset / Trial / NCT00896974

Study of 9cUAB30 in Healthy Participants

NCT00896974 ↗

Phase 1 Completed 15 enrolled National Cancer Institute (NCI)
NaSingle-groupOpen-labelTreatment

Summary

This research study is looking at 9cUAB30 in healthy participants. Studying samples of blood and urine from healthy participants may help doctors learn more about how 9cUAB30 is used by the body.

Timeline

Start
2008-08
Primary completion
2010-03
Completion
2010-03

Drugs

EvaluationDrugModalityDoseRoute
Subject UAB30 Other / unclassified — Oral

Indications

No indication recorded.